Results of the college of american pathology/american college of medical genetics and genomics external proficiency testing from 2006 to 2013 for three conditions prevalent in the Ashkenazi Jewish population

Genetics in Medicine

Volumn 16, Issue 9, 2014, Pages 695-702

  Feldman, Gerald L ^a   Schrijver, Iris ^b   Lyon, Elaine ^c   Palomaki, Glenn E ^d  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ARUP LABORATORIES   (United States)

^d BROWN UNIVERSITY   (United States)

Author keywords

analytic sensitivity; analytic specificity; Ashkenazi Jewish diseases; external proficiency testing; molecular test

Indexed keywords

ARTICLE; ASHKENAZI JEW; CANAVAN DISEASE; CLINICAL LABORATORY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DYSAUTONOMIA; GENOTYPE; HUMAN; MEDICAL SCHOOL; PREVALENCE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TAY SACHS DISEASE; TURNAROUND TIME; DISEASE MANAGEMENT; DYSAUTONOMIA, FAMILIAL; GENETIC SCREENING; GENETICS; GOOD LABORATORY PRACTICE; HEALTH CARE SURVEY; JEW; PROCEDURES; REPRODUCIBILITY; STANDARDS; TAY-SACHS DISEASE;

CANAVAN DISEASE; DISEASE MANAGEMENT; DYSAUTONOMIA, FAMILIAL; GENETIC TESTING; HEALTH CARE SURVEYS; HUMANS; JEWS; LABORATORY PROFICIENCY TESTING; PREVALENCE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TAY-SACHS DISEASE;

EID: 84920511710     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2014.14     Document Type: Article

References (10)

1. Kaplan F. Tay-Sachs disease carrier screening: a model for prevention of genetic disease. Genet Test 1998;2:271-292.
2. Kaback M, Lim-Steele J, Dabholkar D, Brown D, Levy N, Zeiger K. Tay-Sachs disease-carrier screening, prenatal diagnosis, and the molecular era. An international perspective, 1970 to 1993. The International TSD Data Collection Network. JAMA 1993;270:2307-2315.
3. Ostrer H. A genetic profile of contemporary Jewish populations. Nat Rev Genet 2001;2:891-898.
4. ACOG Committee on Genetics. ACOG committee opinion. Number 298, August 2004. Prenatal and preconceptional carrier screening for genetic diseases in individuals of Eastern European Jewish descent. Obstet Gynecol 2004;104:425-428.
5. Grody WW, Cutting GR, Klinger KW, Richards CS, Watson MS, Desnick RJ; Subcommittee on Cystic Fibrosis Screening, Accreditation of Genetic Services Committee, ACMG. American College of Medical Genetics. Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med 2001;3:149-154.
6. Kaback MM, Desnick RJ. Hexosaminidase A Deficiency. 1999 Mar 11 [Updated 11 August 2011]. In: Pagon RA, Adam MP, Bird TD, et al. (eds). GeneReviews [Internet]. University of Washington: Seattle, WA, 1993-2013. http://www. ncbi.nlm.nih.gov/books/NBK1218/. Accessed 12 November 2013.
7. Matalon R, Michals-Matalon K. Canavan Disease. 1999 Sept 16 [Updated 11 August 2011]. In: Pagon RA, Adam MP, Bird TD, et al. (eds). GeneReviews [Internet]. University of Washington: Seattle, WA, 1993-2013. http://www. ncbi.nlm.nih.gov/books/NBK1234/. Accessed 12 November 2013.
8. Shohat M, Halpern GJ. Familial Dysautonomia. 2003 January 21 [Updated 1 June 2010]. In: Pagon RA, Adam MP, Bird TD, et al. (eds). GeneReviews [Internet]. University of Washington: Seattle, WA, 1993-2013. http://www. ncbi.nlm.nih.gov/books/NBK1180/. Accessed 13 November 2013.
9. Palomaki GE, Richards CS. Assessing the analytic validity of molecular testing for Huntington disease using data from an external proficiency testing survey. Genet Med 2012;14:69-75.
10. Weck KE, Zehnbauer B, Datto M, Schrijver I; CAP/ACMG Biochemical and Molecular Genetics Resource Committee. Molecular genetic testing for fragile X syndrome: laboratory performance on the College of American Pathologists proficiency surveys (2001-2009). Genet Med 2012;14:306-312.